Several studies have shown that mice treated with IFN-λ after influenza infection exhibited significantly lower mortality, decreased viral burden, with reduced inflammatory cytokines compared to control underscoring the indispensability of the IFN-λ–IFNLR1 axis (6, 7). The gene discussed is IFNLR1; the disease is influenza.